355 related articles for article (PubMed ID: 21410436)
1. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
Pappalardi MB; McNulty DE; Martin JD; Fisher KE; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Schwartz B; Annan RS; Copeland RA; Tummino PJ; Luo L
Biochem J; 2011 Jun; 436(2):363-9. PubMed ID: 21410436
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
Hewitson KS; Schofield CJ; Ratcliffe PJ
Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
[TBL] [Abstract][Full Text] [Related]
3. Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Tuckerman JR; Zhao Y; Hewitson KS; Tian YM; Pugh CW; Ratcliffe PJ; Mole DR
FEBS Lett; 2004 Oct; 576(1-2):145-50. PubMed ID: 15474027
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.
Pappalardi MB; Martin JD; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Lor L; Schwartz B; Duffy K; Gontarek R; Tummino PJ; Copeland RA; Luo L
Biochemistry; 2008 Oct; 47(43):11165-7. PubMed ID: 18834144
[TBL] [Abstract][Full Text] [Related]
5. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
[TBL] [Abstract][Full Text] [Related]
6. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of a prolyl hydroxylase domain (PHD) by substrate analog peptides.
Kwon HS; Choi YK; Kim JW; Park YK; Yang EG; Ahn DR
Bioorg Med Chem Lett; 2011 Jul; 21(14):4325-8. PubMed ID: 21665470
[TBL] [Abstract][Full Text] [Related]
8. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
9. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
Chen YR; Dai AG; Hu RC
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
[TBL] [Abstract][Full Text] [Related]
10. HIF hydroxylation and cellular oxygen sensing.
Metzen E; Ratcliffe PJ
Biol Chem; 2004; 385(3-4):223-30. PubMed ID: 15134335
[TBL] [Abstract][Full Text] [Related]
11. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HIF: asparaginyl hydroxylation.
Peet D; Linke S
Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ankyrin repeat-containing proteins as substrates of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible transcription factor.
Linke S; Hampton-Smith RJ; Peet DJ
Methods Enzymol; 2007; 435():61-85. PubMed ID: 17998049
[TBL] [Abstract][Full Text] [Related]
14. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
Barth S; Nesper J; Hasgall PA; Wirthner R; Nytko KJ; Edlich F; Katschinski DM; Stiehl DP; Wenger RH; Camenisch G
Mol Cell Biol; 2007 May; 27(10):3758-68. PubMed ID: 17353276
[TBL] [Abstract][Full Text] [Related]
15. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Flashman E; Davies SL; Yeoh KK; Schofield CJ
Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
[TBL] [Abstract][Full Text] [Related]
16. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
Pientka FK; Hu J; Schindler SG; Brix B; Thiel A; Jöhren O; Fandrey J; Berchner-Pfannschmidt U; Depping R
J Cell Sci; 2012 Nov; 125(Pt 21):5168-76. PubMed ID: 22946054
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
18. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.
Villar D; Vara-Vega A; Landázuri MO; Del Peso L
Biochem J; 2007 Dec; 408(2):231-40. PubMed ID: 17725546
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HIF: prolyl hydroxylases.
Stolze IP; Mole DR; Ratcliffe PJ
Novartis Found Symp; 2006; 272():15-25; discussion 25-36. PubMed ID: 16686427
[TBL] [Abstract][Full Text] [Related]
20. Role and regulation of prolyl hydroxylase domain proteins.
Fong GH; Takeda K
Cell Death Differ; 2008 Apr; 15(4):635-41. PubMed ID: 18259202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
